Outlook on the Healthcare-Acquired Infection Global Market to 2026

DUBLIN, July 1, 2021 / PRNewswire / – Healthcare Acquired Infections: Devices, Drugs, and Environmental Products: 2021-2026 report has been added to ResearchAndMarkets.com’s offering.

The report focuses on selected drugs (antimicrobials), environmental treatments (disinfectants, sterilization systems, etc.) and precautions in medical devices (e.g. catheters, patient ventilators, sterile IV filters) that prevent the occurrence of nosocomial infections.

Within each treatment type, regional analyzes focus on America (ie Canada, the USA, Mexico, Central America and South America), EMRA (ie Europe, the middle East, Russia and Africa) and Asia Pacific (ie, Japan, China, India, other west pacific countries like Australia and New Zealandand other Southeast Asian countries).

The report includes:

• 72 tables
• An Updated Look At The Global Healthcare Acquired Infection Control (HCAI) Control Market
• Analyzes of global market trends with data from 2020, estimates for 2021, and projections of average annual growth rates (CAGRs) through 2026
• Highlights of selected antimicrobial drugs and environmental sterilization / disinfection products currently used or in development to treat infections in healthcare
• Market outlook and forecast trends in pharmaceutical treatment (antimicrobial and vaccines), environmental treatment (disinfectants, sterilization systems, etc.), and medical device precautions (catheters, patient ventilators, sterile intravenous ones [IV] Filters) that prevent the occurrence of nosocomial infections
• – Estimate the market size and revenue forecast for the HCAI Control Market and related market share analysis according to key market segments – technology type, application, and geography
• Discussing key market dynamics, industry structure, regulatory approvals, market deterrents, unmet needs, and other factors that fuel the opportunities in microbiological research
• A look at the antimicrobial resistance (AMR) product pipeline, hospital monitoring methods, and tools to control HCAI infection
• Review of US patent grants for innovations in infectious disease control and viral infections
• Profile descriptions of the leading industry players including 3M, Merck, Novartis, Pfizer, Roche and Sanofi

Key topics covered:

Chapter 1 Introduction

• Study goals and objectives
• Reasons for this study
• Scope of report
• Sources of information
• methodology
• Geographical breakdown
• Analyst credentials
• Custom research
• Related reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

• Healthcare Acquired Infections
• Types of Infections
• Central-Line Associated Bloodstream Infections
• Infections of the surgical site
• Catheter-associated urinary tract infections
• Ventilator-associated pneumonia
• Healthcare diseases and infectious agents
• Acinetobacter
• Burkholderia Cepacia
• Clostridium difficile
• Clostridium sordellii
• Enterobacteriaceae (carbapenem-resistant)
• Gram negative bacteria
• hepatitis
• HIV / AIDS
• flu
• Klebsiella
• Methicillin-resistant Staphylococcus aureus
• Mycobacterium abscess
• Norovirus
• Pseudomonas aeruginosa
• Staphylococcus aureus
• Vancomycin-resistant enterococci
• Incidence and prevalence
• Risk factors
• Prevention strategies
• Basic infection prevention and control
• Antibiotics and Multi-Resistant Organisms
• Device-related infection control
• Procedural guidelines
• Establish specific guidelines
• WHO guidelines
• Surveillance systems

Chapter 4 Market Overview and Analysis

• Global Infection Control Market
• Regional analysis
• Market leader
• Antimicrobial resistance
• Growing population and demographic changes
• Emerging markets
• new technologies
• Vaccination protection
• Increased focus on HCAIs
• Market deterrence
• Economics of newer methods
• Unmet needs
• Effective handling of “superbugs”

Chapter 5 Medicines

• HCAI pharmaceutical market
• Antibiotics
• Mechanism of action
• Antibiotic resistance
• Mechanisms of Antibiotic Resistance
• Reasons for Antibiotic Resistance
• Antibiotic resistance (antibiotics): incidence
• Antibiotic resistance: hospitals and health care facilities
• Davos Declaration on Combating Antibiotic Resistance
• Antibiotics for bacterial HCAIs
• Selected marketed antibiotics
• Global Antibiotics Market
• Antifungal drugs
• Antifungal drugs for HCAI
• Selected marketed antifungal drugs
• Global Antifungal Market
• Antivirals and vaccines
• Hepatitis B and hepatitis C.
• flu

Chapter 6 Environmental Treatment

• HCAI: Environmental Treatment Market
• Disinfectants
• Types
• Mainly marketed disinfectants for hospital use
• Prepare the patient’s skin
• The main antiseptics marketed for skin preparation of patients
• Patient Skin Preparation Market
• Environmental sterilization
• Air treatment
• Space filtration systems
• Room pressurization
• UV light disinfection
• Water supply
• Sterilization of devices / systems
• Heat sterilization
• Chemical sterilization
• Radiation-based sterilization
• Environmental sterilization market

Chapter 7 Medical Devices

• HCAI medical device market
• Antimicrobial coatings
• catheter
• Patient ventilators
• Types
• Treatments and Devices
• IV filter
• IV filter market

Chapter 8 Industry Structure

• Industry structure for infection prevention in healthcare
• Delivery
• Customers
• consumer

Chapter 9 Research and Opportunities

• new technologies
• Hand hygiene
• Patient tracking
• Self-disinfecting surfaces
• Automated decontamination technologies
• Intelligent systems and predictive analytics
• Other technologies
• Antibiotics pipeline
• Viral Infection Pipeline: Hepatitis B Treatments
• Pipeline of Viral Infection Influenza Treatments
• Pipeline for the treatment of fungal infections

Chapter 10 Patent / Patent Application Analysis

• drug
• Antibiotics
• Hepatitis B treatments
• Hepatitis C treatments
• Flu treatments
• Antifungal treatments
• Environmental sterilization
• Disinfectants
• Treatments to prepare the patient’s skin
• Air treatment technologies
• Water treatment technologies
• Medical equipment
• Catheters and endotracheal tubes
• IV filter (in-line)

Chapter 11 Company Profiles

• Pharmaceutical company
• Gilead Sciences
• Merck
• Novartis
• Pfizer
• Roche
• Sanofi Pasteur
• Seqirus
• Company in the sterilization / disinfection industry
• 3M Health care
• Advanced sterilization products
• Becton, Dickinson and Company
• Belimed
• The Clorox Company
• Sterigenics
• Xenex disinfection services
• Medical device manufacturer
• Bactiguard
• Teleflex

Chapter 12 Appendix

Please visit https://www.researchandmarkets.com/r/epdrz3 for more information on this report

Media contact:
Research and Markets
Laura wood, Senior manager
[email protected]

For EST office hours, call + 1-917-300-0470. at
For US / CAN toll free call + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900. at

US Fax: 646-607-1904
Fax (outside the US): + 353-1-481-1716

SOURCE Research and Markets

similar links

http://www.researchandmarkets.com

source https://dailyhealthynews.ca/outlook-on-the-healthcare-acquired-infection-global-market-to-2026/